Trial ID or NCT#

NCT01314313

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT and the Edwards SAPIEN 3 transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, severe aortic stenosis.

Official Title

Edwards SAPIEN XT Transcatheter Heart Valve Therapy for Intermediate and High Risk Patients

Eligibility Criteria

Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

D. Craig Miller, M.D.
D. Craig Miller, M.D.
Cardiovascular surgeon
Thelma and Henry Doelger Professor of Cardiovascular Surgery, Emeritus
Alan Yeung, MD
Alan Yeung, MD
Interventional cardiologist, Cardiologist
Li Ka Shing Professor in Cardiology
Rajesh Dash, MD PhD;      Director of SSATHI & CardioClick
Rajesh Dash, MD PhD; Director of SSATHI & CardioClick
Cardiologist
Associate Professor of Medicine (Cardiovascular Medicine)

Contact us to find out if this trial is right for you.

CONTACT

Leigh Trautman, RN
(650) 725-3931